Click to Share
 
 
  1. Latest News
  2. Submit Press Release
Filter News
Show All Results
News By Country
News By Tag
Nmi Remove


September 2015
Sa Fr Th We Tu Mo Su
5 4 3 2 1
August 2015
31 30

nmi Press Releases

  + XML/RSS  



By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI), a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the...
By Nemucore Medical Innovations, Inc.
Worcester Polytechnic Institute grants Provost Award to Joseph Cacaccio and Eileen Wrabel for their major qualifying project work at Nemucore Medical Innovations.
By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI) is a privately-held biopharmaceutical company dedicated to the development and commercialization of targeted nanomedicines for the treatment of patients afflicted with multidrug resistant cancers.
By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc., a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the publication...

All Press Releases

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc., a privately-held biopharmaceutical company dedicated to the development and commercialization of molecularly targeted therapies to treat multidrug resistant cancers, today announced the appointment of Daniel E.
By Nemucore Medical Innovations, Inc.
Election of James B Farinholt Jr. Gives Nemucore's Board a Majority of Independent Directors
By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc., a privately-held biopharmaceutical company dedicated to the development and commercialization of molecularly targeted therapies to treat multidrug resistant cancers, today announced the publication of its paper "EGFR...
By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI), a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the...
By Nemucore Medical Innovations, Inc.
Worcester Polytechnic Institute grants Provost Award to Joseph Cacaccio and Eileen Wrabel for their major qualifying project work at Nemucore Medical Innovations.
By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI) is a privately-held biopharmaceutical company dedicated to the development and commercialization of targeted nanomedicines for the treatment of patients afflicted with multidrug resistant cancers.
By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc., a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the publication...
By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI), a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the...
By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI) announces it has received a Phase I U43 Small Business Innovation research grant from the National Cancer Institute.
By Natural Marketing Institute
NMI has added Patti Marshman-Goldblatt as Senior Vice President and Diane Ray as Vice President-Strategic Consulting. Kurt Wagner, Dave Montgomery, La-Vie Borde-Perry, Gail Sayer and Deb Morang were hired as Project Directors.
By Nancy White
Fourth in a series of 10 releases based on NMI’s Top Ten Trends of 2007
By The Natural Marketing Institute
First in a series of seven trends based on NMI's extensive LOHAS consumer insight.


Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share